Idec regulatory update

Idec Pharmaceuticals Corp. Idec Pharmaceuticals Corp. received a notice of allowance for a U.S. patent covering its Melimmune-2 therapeutic vaccine for melanoma. IDPH said the vaccine stimulates B ce...